Change point analyses in prodromal Alzheimer’s disease
Change point analysis can reveal when a biomarker starts to diverge from the pattern of normal aging. This paper analyzes several biomarkers from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to estimate the sequence and timing of their change points relative to a subsequent clinical diagno...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Biomarkers in Neuropsychiatry |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666144620300186 |